3 hours ago
1
Eoneren/E+ via Getty Images
- Niagen Bioscience (NASDAQ:NAGE) said on Tuesday it has signed an exclusive global commercial license agreement with Haukeland University Hospital located in Bergen, Norway.
- This agreement grants Niagen exclusive rights to a range of proprietary intellectual property, including valuable data.
- Additionally, as part of this agreement, the company said it has created a wholly owned subsidiary to further its business interests.
English (US) ·